Search results for “Intravenous gammaglobulin” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 3,656 patents, we discovered top 451 key players by total patent application. Ablynx NV, F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc. are dominant in this area. They take 13.21% of the total patent filing.
Ablynx NV
Oost-Vlaanderen, Belgium
Patent: 280
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 116
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 87
Sanofi SA
France
Patent: 84
Bristol Myers Squibb Co.
New York, United States
Patent: 79
Pfizer Inc.
New York, United States
Patent: 66
Genentech, Inc.
California, United States
Patent: 57
CSL Behring AG
Switzerland
Patent: 54
Amgen Fremont, Inc.
California, United States
Patent: 54
Merck Patent GmbH
Hessen, Germany
Patent: 49
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 117 patents, we discovered top 22 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Navigo Proteins GmbH, Viela Bio, Inc. are active in this area.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 31
STARTUP
Navigo Proteins GmbH
Niedersachsen, Germany
Patent: 11
STARTUP
Viela Bio, Inc.
United States
Patent: 11
STARTUP
iOmx Therapeutics AG
Bayern, Germany
Patent: 10
STARTUP
Orum Therapeutics, Inc.
South Korea
Patent: 9
STARTUP
Attralus, Inc.
California, United States
Patent: 8
STARTUP
Marengo Therapeutics, Inc.
Massachusetts, United States
Patent: 5
STARTUP
Inflazome Ltd.
DUBLIN, Ireland
Patent: 4
STARTUP
Polyneuron Pharmaceuticals AG
Basel-Stadt, Switzerland
Patent: 4
STARTUP
Rapid Novor, Inc.
Ontario, Canada
Patent: 3
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 2,171 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Ablynx NV, Sanofi SA, Memorial Sloan-Kettering Cancer Center take 13.96% of patent filing during this period.
Ablynx NV
Oost-Vlaanderen, Belgium
Patent: 157
Sanofi SA
France
Patent: 78
Memorial Sloan-Kettering Cancer Center
New York, United States
Patent: 68
Bristol Myers Squibb Co.
New York, United States
Patent: 63
Good T Cells Inc
United States
Patent: 45
Five Prime Therapeutics, Inc.
California, United States
Patent: 40
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 36
Momenta Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 32
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 28
Merck Patent GmbH
Hessen, Germany
Patent: 26
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 2,171 patents in last 5 years, we discover 337 new entrants. Good T Cells Inc, Five Prime Therapeutics, Inc., Momenta Pharmaceuticals, Inc. are the most active new entrants in this area.
Good T Cells Inc
United States
Patent: 45
Five Prime Therapeutics, Inc.
California, United States
Patent: 40
Momenta Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 32
Sorbonne Université
France
Patent: 23
Spark Therapeutics, Inc.
Pennsylvania, United States
Patent: 21
Généthon
France
Patent: 19
Merck Sharp & Dohme LLC
New Jersey, United States
Patent: 19
LG Chem Ltd.
South Korea
Patent: 18
Monoquant Pty Ltd
Australia
Patent: 14
Jiangsu Alphamab Biopharmaceuticals Co. Ltd
Jiangsu Sheng, China
Patent: 11
Research Institutions
Order by:
Innovation Intensity
With the analysis among 797 patents, we discovered top 154 universities and scientific research institutions by total patent application. Vlaams Instituut voor Biotechnologie - Flanders Institute, Dartmouth College, Sorbonne Université are dominant in this area. They take 17.69% of the total patent filing.
Vlaams Instituut voor Biotechnologie - Flanders Institute
Belgium
Patent: 33
Dartmouth College
New Hampshire, United States
Patent: 28
Sorbonne Université
France
Patent: 23
The Scripps Research Institute
California, United States
Patent: 20
Ghent University
Oost-Vlaanderen, Belgium
Patent: 19
King's College London
United Kingdom
Patent: 12
Vrije Universiteit Brussel
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 12
University of Oslo
Oslo, Norway
Patent: 11
Yale University
Connecticut, United States
Patent: 10
Université de Paris
France
Patent: 10
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: